Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Hyon K. Choi, M.D.

Co-Author

This page shows the publications co-authored by Hyon Choi and John Stone.
Connection Strength

3.682
  1. ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry. J Rheumatol. 2021 07; 48(7):1060-1064.
    View in: PubMed
    Score: 0.236
  2. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford). 2020 09 01; 59(9):2308-2315.
    View in: PubMed
    Score: 0.229
  3. Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2019 11; 71(11):1879-1887.
    View in: PubMed
    Score: 0.214
  4. Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis. Ann Rheum Dis. 2020 04; 79(4):e40.
    View in: PubMed
    Score: 0.205
  5. An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken). 2018 11; 70(11):1671-1678.
    View in: PubMed
    Score: 0.202
  6. Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System. Arthritis Care Res (Hoboken). 2018 10; 70(10):1495-1500.
    View in: PubMed
    Score: 0.199
  7. Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Ann Rheum Dis. 2018 09; 77(9):1333-1338.
    View in: PubMed
    Score: 0.195
  8. Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2017 07; 69(7):1004-1010.
    View in: PubMed
    Score: 0.184
  9. Nationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2017 06; 69(6):915-921.
    View in: PubMed
    Score: 0.182
  10. Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis. Arthritis Rheumatol. 2017 01; 69(1):176-184.
    View in: PubMed
    Score: 0.178
  11. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Arthritis Rheumatol. 2016 12; 68(12):2945-2952.
    View in: PubMed
    Score: 0.177
  12. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 09; 68(9):2283-9.
    View in: PubMed
    Score: 0.174
  13. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis. Ann Rheum Dis. 2017 Mar; 76(3):543-546.
    View in: PubMed
    Score: 0.172
  14. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016 Jun; 55(6):1000-8.
    View in: PubMed
    Score: 0.167
  15. Improved survival in granulomatosis with polyangiitis: A general population-based study. Semin Arthritis Rheum. 2016 Feb; 45(4):483-9.
    View in: PubMed
    Score: 0.161
  16. The association of smoking with immunoglobulin G4-related disease: a case-control study. Rheumatology (Oxford). 2021 Nov 03; 60(11):5310-5317.
    View in: PubMed
    Score: 0.062
  17. Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System. ACR Open Rheumatol. 2021 Oct 12.
    View in: PubMed
    Score: 0.062
  18. Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study. Semin Arthritis Rheum. 2021 Sep 26; 51(6):1180-1185.
    View in: PubMed
    Score: 0.062
  19. Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic. ACR Open Rheumatol. 2021 Sep 08.
    View in: PubMed
    Score: 0.061
  20. Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study. Semin Arthritis Rheum. 2021 02; 51(1):150-157.
    View in: PubMed
    Score: 0.059
  21. Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study. Arthritis Care Res (Hoboken). 2020 Dec 20.
    View in: PubMed
    Score: 0.058
  22. Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study. Arthritis Care Res (Hoboken). 2020 11; 72(11):1543-1549.
    View in: PubMed
    Score: 0.058
  23. Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. JAMA Intern Med. 2020 06 01; 180(6):870-876.
    View in: PubMed
    Score: 0.056
  24. Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis. ACR Open Rheumatol. 2020 May; 2(5):261-268.
    View in: PubMed
    Score: 0.056
  25. Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race. Ann Allergy Asthma Immunol. 2020 08; 125(2):190-195.e2.
    View in: PubMed
    Score: 0.056
  26. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 01; 79(1):77-87.
    View in: PubMed
    Score: 0.054
  27. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020 01; 72(1):7-19.
    View in: PubMed
    Score: 0.054
  28. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 03; 78(3):406-412.
    View in: PubMed
    Score: 0.051
  29. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis. 2016 Jun; 75(6):1166-9.
    View in: PubMed
    Score: 0.041
  30. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002 May; 46(5):1309-18.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.